Montserrat Miñarro Carmona

ORCID: 0000-0002-6795-2685
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug Solubulity and Delivery Systems
  • Analytical Methods in Pharmaceuticals
  • Higher Education Teaching and Evaluation
  • Analytical Chemistry and Chromatography
  • Pharmaceutical Practices and Patient Outcomes
  • E-Learning and Knowledge Management
  • RNA Interference and Gene Delivery
  • Advanced Drug Delivery Systems
  • Innovations in Medical Education
  • Protein purification and stability
  • Educational Technology in Learning
  • Pharmaceutical studies and practices
  • Advancements in Transdermal Drug Delivery
  • Pharmacology and Obesity Treatment
  • Microencapsulation and Drying Processes
  • Lipid Membrane Structure and Behavior
  • Antibiotics Pharmacokinetics and Efficacy
  • Advanced biosensing and bioanalysis techniques
  • Health Systems, Economic Evaluations, Quality of Life
  • Hydrogels: synthesis, properties, applications
  • Intimate Partner and Family Violence
  • Quality and Safety in Healthcare
  • Safe Handling of Antineoplastic Drugs
  • Healthcare Systems and Technology
  • Educational Research and Science Teaching

Universitat de Barcelona
2015-2025

Institut d'Investigació Biomédica de Bellvitge
2014-2025

Agencia de Evaluación de Tecnologías Sanitarias
2023

Instituto de Salud Carlos III
2023

Duran i Reynals Hospital
2015-2019

Pharmaceutical Biotechnology (Czechia)
2016

Hospital Universitario Puerta de Hierro Majadahonda
2013

Pharmaceutical Product Development (India)
2011

Corporació Sanitària Parc Taulí
2010

This study explores the development and characterization of lyophilized chondroitin sulfate (CHON)-loaded solid lipid nanoparticles (SLN) as an innovative platform for advanced drug delivery. Background/Objectives: Solid are increasingly recognized their biocompatibility, ability to encapsulate diverse compounds, capacity enhance stability, bioavailability, therapeutic efficacy. Methods: CHON, a naturally occurring glycosaminoglycan with anti-inflammatory regenerative properties, was...

10.3390/pharmaceutics17010086 article EN cc-by Pharmaceutics 2025-01-10

Context: The SeDeM expert system is based on the experimental study and quantitative determination of characterization parameters powdered substances, aim being to determine whether a substance suitable for producing tablets by means direct compression (DC) technology, thereby reducing lead time pre-formulation studies. Additionally, this also provides formulations with minimum number excipients.Objective: We used analyze formulas production orodispersible ibuprofen tablets.Method:...

10.3109/03639045.2012.756007 article EN Drug Development and Industrial Pharmacy 2013-01-24

A previously published HPLC method for the simultaneous determination of six major components (hydroquinone, kojic acid, octinoxate, avobenzone, butylated hydroxyanisole, and hydroxytoluene) in a skin-whitening cream was transferred optimized to an ultra-performance LC system. Separation achieved ZORBAX SB-Phenyl Rapid-Resolution High Throughput column (2.1 × 100 mm, 1.8 μm), using mobile phase consisting water with 0.1% acetic acid acetonitrile at flow rate 0.7 mL/min. The maintained 40°C,...

10.5740/jaoacint.16-0104 article EN Journal of AOAC International 2016-10-01

Hydrophilic matrix tablets are a type of sustained release dosage form characterized by distributing drug in that is usually polymeric. Tolcapone inhibits the enzyme catechol-O-methyl transferase. In recent years, it has been shown tolcapone potent inhibitor amyloid aggregation process transthyretin protein, and acts stabilizing structure reducing progression familial polyneuropathy. The main objective this study was to obtain tablet for oral administration with preferred regimen 1 every 12...

10.3390/pharmaceutics12070674 article EN cc-by Pharmaceutics 2020-07-17
Coming Soon ...